Replies to post #208604 on Biotech Values

[mcbio]

CATB -69%/AH on failed trial in DMD

Not that CATB can't turn things around (they can), but I suspected there was a red-flag on this one early on: #msg-114730125 .

[DewDiligence]

CATB -62%/AH on phase-3 failure in DMD:

https://finance.yahoo.com/news/catabasis-pharmaceuticals-announces-top-line-210000899.html

Time warp? #msg-128312561.